Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$799M |
| 2 |
Tesla
TSLA
|
+$295M |
| 3 |
PPG Industries
PPG
|
+$256M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$256M |
| 5 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 5 |
Apple
AAPL
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.3% |
| 2 | Healthcare | 8.05% |
| 3 | Financials | 7.53% |
| 4 | Consumer Discretionary | 6.73% |
| 5 | Industrials | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Fresenius Medical Care
FMS
$12.7B
| $364K | ﹤0.01% |
11,224
+3,153
| +39% | +$104K |
|
|
DGL
4727
DELISTED
Invesco DB Gold Fund
DGL
| $364K | ﹤0.01% |
6,964
-8,132
| -54% | -$419K |
|
4728
Spero Therapeutics
SPRO
$71.2M
| $363K | ﹤0.01% |
22,694
+14,928
| +192% | +$237K |
|
|
AMYT
4729
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $363K | ﹤0.01% |
33,625
-604
| -2% | -$6.52K |
|
4730
Establishment Labs
ESTA
$2.21B
| $362K | ﹤0.01% |
5,350
-16,219
| -75% | -$1.13M |
|
4731
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
$303M
| $361K | ﹤0.01% |
10,721
+1
| +0% | +$34 |
|
|
GLQ
4732
Clough Global Equity Fund
GLQ
$157M
| $361K | ﹤0.01% |
27,487
-320
| -1% | -$4.69K |
|
4733
Limoneira
LMNR
$254M
| $361K | ﹤0.01% |
24,011
+12,354
| +106% | +$194K |
|
|
AKTS
4734
DELISTED
Akoustis Technologies Inc
AKTS
| $361K | ﹤0.01% |
54,173
+30,563
| +129% | +$228K |
|
4735
VanEck Pharmaceutical ETF
PPH
$996M
| $360K | ﹤0.01% |
4,679
+1
| +0% | +$74 |
|
4736
Runway Growth Finance
RWAY
$281M
| $359K | ﹤0.01% |
+28,030
| New | +$363K |
|
4737
Global X Guru Index ETF
GURU
$63.4M
| $357K | ﹤0.01% |
7,540
-570
| -7% | -$27.8K |
|
4738
UNIFI
UFI
$129M
| $357K | ﹤0.01% |
15,422
-64,907
| -81% | -$1.48M |
|
4739
VistaGen Therapeutics
VTGN
$11.9M
| $356K | ﹤0.01% |
6,090
+3,225
| +113% | +$210K |
|
|
NAGE
4740
Niagen Bioscience
NAGE
$244M
| $356K | ﹤0.01% |
95,304
+16,622
| +21% | +$89.7K |
|
|
ORC
4741
Orchid Island Capital
ORC
$1.31B
| $355K | ﹤0.01% |
15,739
-20,052
| -56% | -$480K |
|
|
ACBI
4742
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $355K | ﹤0.01% |
12,328
+10,690
| +653% | +$302K |
|
|
LONA
4743
LeonaBio Inc
LONA
$71.6M
| $354K | ﹤0.01% |
2,723
+2,713
| +27,130% | +$343K |
|
4744
Futu Holdings
FUTU
$14.7B
| $354K | ﹤0.01% |
8,173
-2,467
| -23% | -$141K |
|
4745
Tenaya Therapeutics
TNYA
$168M
| $354K | ﹤0.01% |
18,672
+18,595
| +24,149% | +$405K |
|
|
TECX
4746
Tectonic Therapeutic
TECX
$623M
| $354K | ﹤0.01% |
7,662
+2,787
| +57% | +$160K |
|
|
VOXX
4747
DELISTED
VOXX International Corporation Class A
VOXX
| $354K | ﹤0.01% |
34,820
+23,768
| +215% | +$264K |
|
4748
CALL
Synchrony
SYF
$25.5B
| $353K | ﹤0.01% |
+7,600
| New | +$365K |
|
|
4749
PUT
Synchrony
SYF
$25.5B
| $353K | ﹤0.01% |
+7,600
| New | +$365K |
|
|
CPLG
4750
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $352K | ﹤0.01% |
22,401
-42,839
| -66% | -$676K |
|
Similar funds
Wells Fargo's Q4 2021 Portfolio in Review
As of Q4 2021, Wells Fargo held 8,381 positions worth $401B, down 12% from $455B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wells Fargo withdrew a net $88.2B in Q4 2021, closing 389 positions and reducing 3,415 holdings. Its most notable exit was Kansas City Southern, an estimated $61.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wells Fargo opened a new position in Bank of America Series L worth $44.7M.
- Wells Fargo's largest Q4 2021 buy was Bank of America Series L: 30,939 shares worth $44.7M.
- Wells Fargo added most to Vanguard Morningstar Mid-Cap ETF in Q4 2021, an estimated $799M increase.
- Wells Fargo's biggest Q4 2021 reduction was Microsoft, cutting an estimated $3.11B.
- Wells Fargo fully exited Kansas City Southern in Q4 2021, selling an estimated $61.9M.
- Wells Fargo's ten largest holdings make up 18% of its $401B portfolio in Q4 2021.
- Wells Fargo opened 685 new positions and closed 389 in Q4 2021.
- Wells Fargo's portfolio value fell 12% quarter-over-quarter to $401B.
Based on Wells Fargo's 13F filing for Q4 2021, filed 14 Feb 2022.